Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expert panel recommendations
Authors:
- Uzung YoonUYUzung Yoon
- the ERAS4OLT.org Working GroupTGthe ERAS4OLT.org Working Group
- 1 October 2022
- journal article
- review article
- Published by Wiley in Clinical Transplantation
- Vol. 36 (10) , e14637
Abstract
Background: Liver transplantation (LT) is frequently complicated by coagulopathy associated with end‐stage liver disease (ESLD), that is, often multifactorial.Objectives: The objective of this systematic review was to identify evidence based intraoperative transfusion and coagulation management strategies that improve immediate and short‐term outcomes after LT.Methods: PRISMA‐guidelines and GRADE‐approach were followed. Three subquestions were formulated. (Q); Q1: transfusion management; Q2: antifibrinolytic therapy; and Q3: coagulation monitoring.Results: Sixteen studies were included for Q1, six for Q2, and 10 for Q3. Q1: PRBC and platelet transfusions were associated with higher mortality. The use of prothrombin complex concentrate (PCC) and fibrinogen concentrate (FC) were not associated with reductions in intraoperative transfusion or increased thrombotic events. The use of cell salvage was not associated with hepatocellular carcinoma (HCC) recurrence or mortality. Cell salvage and transfusion education significantly decreased blood product transfusions. Q2: Epsilon‐aminocaproic acid (EACA) and tranexamic acid (TXA) were not associated with decreased blood product transfusion, improvements in patient or graft survival, or increases in thrombotic events. Q3: Viscoelastic testing (VET) was associated with decreased allogeneic blood product transfusion compared to conventional coagulation tests (CCT) and is likely to be cost‐effective. Coagulation management guided by VET may be associated with increases in FC and PCC use.Conclusion: Q1: A specific blood product transfusion practice is not recommended (QOE; low | Recommendation; weak). Cell salvage and educational interventions are recommended (QOE: low | Grade of Recommendation: moderate). Q2: The routine use of antifibrinolytics is not recommended (QOE; low | Recommendation; weak). Q3: The use of VET is recommended (QOE; low‐moderate | Recommendation; strong).Keywords
This publication has 50 references indexed in Scilit:
- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strengthJournal of Clinical Epidemiology, 2013
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Blood Transfusion Requirement During Liver Transplantation Is an Important Risk Factor for MortalityJournal of the American College of Surgeons, 2013
- Aprotinin Versus Tranexamic Acid During Liver Transplantation: Impact on Blood Product Requirements and SurvivalTransplantation, 2011
- Detrimental Effect of Aprotinin Ban on Amount of Blood Loss During Liver Transplantation: Single-Center ExperienceTransplantation Proceedings, 2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Thromboelastography-Guided Transfusion Decreases Intraoperative Blood Transfusion During Orthotopic Liver Transplantation: Randomized Clinical TrialTransplantation Proceedings, 2010
- A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac SurgeryNew England Journal of Medicine, 2008
- Coagulation and Liver TransplantationInternational Anesthesiology Clinics, 2006
- Coagulation and liver transplantation: Current conceptsLiver Transplantation and Surgery, 1997